Jpmorgan Chase & CO Novo Nordisk A S Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,409,228 shares of NVO stock, worth $569 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,409,228

Previous 4,936,869 9.57%

Holding current value

$569 Million

Previous $705 Million 8.6%

% of portfolio

0.05%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$119.07 - $145.42 $56.2 Million - $68.7 Million	472,359 Added 9.57%	5,409,228 $644 Million
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $83.8 Million - $100 Million	-682,706 Reduced 12.15%	4,936,869 $705 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $89.6 Million - $119 Million	877,751 Added 18.51%	5,619,575 $722 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $235 Million - $282 Million	2,678,732 Added 129.84%	4,741,824 $491 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $103 Million - $226 Million	1,130,687 Added 121.27%	2,063,092 $188 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $2.36 Million - $2.62 Million	15,150 Added 1.65%	932,405 $151 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $10.7 Million - $12.8 Million	-80,485 Reduced 8.07%	917,255 $146 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $12.5 Million - $16.5 Million	-121,720 Reduced 10.87%	997,740 $135 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $94,327 - $115,760	990 Added 0.09%	1,119,460 $112 Million
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $34.4 Million - $40.6 Million	333,259 Added 42.44%	1,118,470 $125 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $34.4 Million - $41.6 Million	369,791 Added 89.02%	785,211 $87.2 Million
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $4.88 Million - $5.96 Million	50,898 Added 13.96%	415,420 $46.5 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $30.8 Million - $38.9 Million	364,522 New	364,522 $35 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Novo Nordisk A S Transaction History